title: Commentary on - "Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction".
authors: De-Hong
authors: DH
authors: Cao
authors: Liang-Ren
authors: LR
authors: Liu
authors: Department of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
authors: Qiang
authors: Q
authors: Wei
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use*; D011743:Pyrimidines / Q000008:administration & dosage* / Q000627:therapeutic use*; D013449:Sulfonamides / Q000008:administration & dosage* / Q000627:therapeutic use*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides
references: J Sex Med. 2011 Jul;8(7):2048-61
references: 21554549
references: J Sex Med. 2009 Nov;6(11):3166-76
references: 19694927
references: Asian J Androl. 2015 Jan-Feb;17(1):143-8
references: 25155105
references: Andrology. 2013 Jul;1(4):549-55
references: 23785019
references: Ther Clin Risk Manag. 2014 May 14;10:341-54
references: 24868160
references: Eur Urol. 2011 Aug;60(2):380-7
references: 21458153